Research is the foundation upon which Lupin Pharmaceuticals, Inc. will participate in a variety of therapeutic areas.
|The Lupin Research Park is located at Pune, India.|
|19 acre site with built area of 150,000 sq.ft.|
|Home to 320 scientists.|
|Lupin's core site for innovation:|
|- Process development;|
|- Technology development;|
|- Basic preclinical, phase1 and phase 2 research.|
|145 patents filed, 53 patents granted worldwide.|
|Works closely with an extensive network of global laboratories, companies and academic institutions.|
|Drug master files (DMFs) for APIs and Formulation development.|
|Abbreviated new drug applications (ANDAs) for finished products.|
New Drug Delivery Systems (NDDS).
|Oral controlled release systems (OCRS).|
|Advanced drug delivery systems (ADDS).|
|Taste masking system.|
New Chemical Entities (NCE).
|Basic drug discovery research has yielded proprietary molecules with potential as anti-migraine, anti-TB, anti-psoriasis agents.|
|Investigating herbal and synthetic routes.|